» Articles » PMID: 35885633

Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays

Overview
Specialty Radiology
Date 2022 Jul 27
PMID 35885633
Authors
Affiliations
Soon will be listed here.
Abstract

The strong non-covalent interaction between biotin and streptavidin places streptavidin-based assays, used by many laboratories, at an increased risk of interference by biotin. At present, a few manufacturers have developed fully automated anti-biotin interference methods, although compared with many detection platforms, these remain insufficient. Additionally, there is a need for more methods that can achieve fully automated anti-biotin interference. We sought to develop and evaluate a new biotin interference-resisting method based on a biotin-streptavidin chemiluminescence immunoassay. Streptavidin-coated magnetic microparticles (M) of different concentrations were prepared and tested for their biotin-resistance capabilities in an automated setting (Cobas e 601). The precision, accuracy, and detection capability were also assessed. Higher concentrations of M were found to have a stronger ability to resist biotin interference. A 2.16 mg/mL concentration of M was able to resist 500 ng/mL of biotin in samples while simultaneously having a relatively weak shielding effect on the optical signals. Moreover, the total precision and accuracy of this method, designated as M3, met acceptable standards. M3 has an improved ability to resist biotin interference, can achieve full automation, and its detection performance can meet the general laboratory quality requirements.

Citing Articles

Effects of High-Biotin Sample Interference on Antibody Concentrations in Sandwich Immunoassays.

Balieiro Neto G, Filho J, Budino F, Freitas A, Soares W Vaccines (Basel). 2023; 11(11).

PMID: 38005959 PMC: 10674817. DOI: 10.3390/vaccines11111627.


An Analysis of the Biotin-(Strept)avidin System in Immunoassays: Interference and Mitigation Strategies.

Balzer A, Whitehurst C Curr Issues Mol Biol. 2023; 45(11):8733-8754.

PMID: 37998726 PMC: 10670868. DOI: 10.3390/cimb45110549.


Selected Technical Aspects of Molecular Allergy Diagnostics.

Lis K, Bartuzi Z Curr Issues Mol Biol. 2023; 45(7):5481-5493.

PMID: 37504263 PMC: 10378047. DOI: 10.3390/cimb45070347.

References
1.
Samarasinghe S, Meah F, Singh V, Basit A, Emanuele N, Emanuele M . BIOTIN INTERFERENCE WITH ROUTINE CLINICAL IMMUNOASSAYS: UNDERSTAND THE CAUSES AND MITIGATE THE RISKS. Endocr Pract. 2017; 23(8):989-998. DOI: 10.4158/EP171761.RA. View

2.
Trambas C, Lu Z, Yen T, Sikaris K . Depletion of biotin using streptavidin-coated microparticles: a validated solution to the problem of biotin interference in streptavidin-biotin immunoassays. Ann Clin Biochem. 2017; 55(2):216-226. DOI: 10.1177/0004563217707783. View

3.
Bevins N, Hubbard J, Fitzgerald R, Kelner M . A Dilution Method to Mitigate Biotin Interference in Cardiac Troponin T Testing. J Appl Lab Med. 2019; 4(3):415-421. DOI: 10.1373/jalm.2018.028589. View

4.
Yang J, Wiencek J . Mitigating biotin interference in two Roche immunoassays by premixing biotinylated capturing molecules with streptavidin coated beads. Clin Chim Acta. 2020; 505:130-135. DOI: 10.1016/j.cca.2020.02.021. View

5.
Avery G . Biotin interference in immunoassay: a review for the laboratory scientist. Ann Clin Biochem. 2019; 56(4):424-430. DOI: 10.1177/0004563219842231. View